AC Immune SA | CIK:0001651625 | 3

  • Filed: 3/20/2018
  • Entity registrant name: AC Immune SA (CIK: 0001651625)
  • Generator: EDGARfilings PROfile
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1651625/000095010318003508/0000950103-18-003508-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1651625/000095010318003508/aciu-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001651625
  • Open this page in separate window: Click

    • ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory

    The following table summarizes equity settled share option grants since inception under each plan:

    PLAN
    		 
    Number of options awarded (since inception)
    		 
    Vesting conditions
    		 
    Contractual life of options
    Share option plan A
    		 
    362,750
    		 
    At grant
    		 
    15.5 years
    Share option plan B
    		 
    819,000
    		 
    At grant
    		 
    10.5 years
    Share option plan C1
    		 
    6,775,250
    		 
    4 years’ service from grant date
    		 
    10 years
    2016 Share Option and Incentive Plan:
    		    
    Executives and Directors
    		 
    257,916
    		 
    4 years’ service from the date of grant, quarterly
    		 
    10 years
    Employees
    		 
    18,850
    		 
    4 years’ service from the date of grant, annually
    		 
    10 years